135 related articles for article (PubMed ID: 24515759)
1. Loss of PTEN expression is associated with IGFBP2 expression, younger age, and late stage in triple-negative breast cancer.
Dean SJ; Perks CM; Holly JM; Bhoo-Pathy N; Looi LM; Mohammed NA; Mun KS; Teo SH; Koobotse MO; Yip CH; Rhodes A
Am J Clin Pathol; 2014 Mar; 141(3):323-33. PubMed ID: 24515759
[TBL] [Abstract][Full Text] [Related]
2. Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer.
Inanc M; Ozkan M; Karaca H; Berk V; Bozkurt O; Duran AO; Ozaslan E; Akgun H; Tekelioglu F; Elmali F
Med Oncol; 2014 Jan; 31(1):801. PubMed ID: 24326984
[TBL] [Abstract][Full Text] [Related]
3. Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer.
Beg S; Siraj AK; Prabhakaran S; Jehan Z; Ajarim D; Al-Dayel F; Tulbah A; Al-Kuraya KS
Breast Cancer Res Treat; 2015 Jun; 151(3):541-53. PubMed ID: 25981902
[TBL] [Abstract][Full Text] [Related]
4. Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer.
Iqbal J; Thike AA; Cheok PY; Tse GM; Tan PH
Histopathology; 2012 Oct; 61(4):652-9. PubMed ID: 22759273
[TBL] [Abstract][Full Text] [Related]
5. ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer.
Wang J; Zhang C; Chen K; Tang H; Tang J; Song C; Xie X
Breast Cancer Res Treat; 2015 Jul; 152(2):255-69. PubMed ID: 26070269
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population.
Hashmi AA; Naz S; Hashmi SK; Hussain ZF; Irfan M; Bakar SMA; Faridi N; Khan A; Edhi MM
BMC Res Notes; 2018 Jun; 11(1):372. PubMed ID: 29884220
[TBL] [Abstract][Full Text] [Related]
7. The role of insulin-like-growth factor binding protein 2 (IGFBP2) and phosphatase and tensin homologue (PTEN) in the regulation of myoblast differentiation and hypertrophy.
Sharples AP; Al-Shanti N; Hughes DC; Lewis MP; Stewart CE
Growth Horm IGF Res; 2013 Jun; 23(3):53-61. PubMed ID: 23583027
[TBL] [Abstract][Full Text] [Related]
8. A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma.
Tavares MC; Sampaio CD; Lima GE; Andrade VP; Gonçalves DG; Macedo MP; Cordeiro de Lima VC
BMC Cancer; 2021 Aug; 21(1):901. PubMed ID: 34362334
[TBL] [Abstract][Full Text] [Related]
9. Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer.
Phuah SY; Looi LM; Hassan N; Rhodes A; Dean S; Taib NA; Yip CH; Teo SH
Breast Cancer Res; 2012 Nov; 14(6):R142. PubMed ID: 23116406
[TBL] [Abstract][Full Text] [Related]
10. [Expression of PTEN, p53 and EGFR in the molecular subtypes of breast carcinoma and
the correlation among them].
Li X; Wang Q; Fu L; Liu M; Yu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 40(9):973-8. PubMed ID: 26408616
[TBL] [Abstract][Full Text] [Related]
11. WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer.
Ertay A; Liu H; Liu D; Peng P; Hill C; Xiong H; Hancock D; Yuan X; Przewloka MR; Coldwell M; Howell M; Skipp P; Ewing RM; Downward J; Wang Y
Cell Death Dis; 2020 Nov; 11(11):1001. PubMed ID: 33221821
[TBL] [Abstract][Full Text] [Related]
12. YY1-regulated LINC00152 promotes triple negative breast cancer progression by affecting on stability of PTEN protein.
Shen X; Zhong J; Yu P; Zhao Q; Huang T
Biochem Biophys Res Commun; 2019 Feb; 509(2):448-454. PubMed ID: 30594392
[TBL] [Abstract][Full Text] [Related]
13. Expression and Clinical Significance of Claudin-7, PDL-1, PTEN, c-Kit, c-Met, c-Myc, ALK, CK5/6, CK17, p53, EGFR, Ki67, p63 in Triple-negative Breast Cancer-A Single Centre Prospective Observational Study.
Constantinou C; Papadopoulos S; Karyda E; Alexopoulos A; Agnanti N; Batistatou A; Harisis H
In Vivo; 2018; 32(2):303-311. PubMed ID: 29475913
[TBL] [Abstract][Full Text] [Related]
14. The combination of everolimus and terameprocol exerts synergistic antiproliferative effects in endometrial cancer: molecular role of insulin-like growth factor binding protein 2.
Chao A; Lin CY; Wu RC; Lee YS; Lee LY; Tsai CL; Yang LY; Liu H; Chen SJ; Wang TH; Lai CH
J Mol Med (Berl); 2018 Nov; 96(11):1251-1266. PubMed ID: 30298385
[TBL] [Abstract][Full Text] [Related]
15. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
[TBL] [Abstract][Full Text] [Related]
16. Trastuzumab resistance induces EMT to transform HER2(+) PTEN(-) to a triple negative breast cancer that requires unique treatment options.
Burnett JP; Korkaya H; Ouzounova MD; Jiang H; Conley SJ; Newman BW; Sun L; Connarn JN; Chen CS; Zhang N; Wicha MS; Sun D
Sci Rep; 2015 Nov; 5():15821. PubMed ID: 26522776
[TBL] [Abstract][Full Text] [Related]
17. PTEN mediates the cross talk between breast and glial cells in brain metastases leading to rapid disease progression.
Hohensee I; Chuang HN; Grottke A; Werner S; Schulte A; Horn S; Lamszus K; Bartkowiak K; Witzel I; Westphal M; Matschke J; Glatzel M; Jücker M; Pukrop T; Pantel K; Wikman H
Oncotarget; 2017 Jan; 8(4):6155-6168. PubMed ID: 28008153
[TBL] [Abstract][Full Text] [Related]
18. IGFBP2 expression predicts IDH-mutant glioma patient survival.
Huang LE; Cohen AL; Colman H; Jensen RL; Fults DW; Couldwell WT
Oncotarget; 2017 Jan; 8(1):191-202. PubMed ID: 27852048
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 protein product in triple negative breast cancers and relation with clinical and histopathological parameters.
Jasar D; Smichkoska S; Kubelka K; Filipovski V; Petrushevska G
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):69-79. PubMed ID: 26076776
[TBL] [Abstract][Full Text] [Related]
20. Is insulin-like growth factor binding protein 2 associated with metastasis in lung cancer?
Hu Q; Huang L; Kuang X; Zhang H; Ling G; Chen X; Li K; Deng Z; Zhou J
Clin Exp Metastasis; 2014 Jun; 31(5):535-41. PubMed ID: 24682597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
